Approval · Notice of Compliance 11011 · 2010
RABAVERT: Notice of Compliance 11011
Issued February 5, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11011
- Date
- February 5, 2010
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RABAVERT | 02267667 | Marketed |
Medicinal ingredients
- RABIES VACCINE (PURIFIED CHICK EMBRYO CELL CULTURE) 2.5 UNIT per DOSE